Integrated DNA Technologies, a leader in genomics, expands its operations with a new synthetic biology manufacturing facility in the U.S. to meet growing demand. Additionally, the company opens a therapeutic manufacturing plant and celebrates 30 years of genomics advocacy. Its Singapore DNA manufacturing facility further underscores its global reach and commitment to innovation.